1.. Introduction   {#sec1}
==================

Between 2003 and 2004, *Severe acute respiratory syndrome coronavirus* (SARS-CoV) caused a worldwide epidemic and had a significant economic impact in countries affected by the outbreak (Lai, 2003[@bb10]). In 2004, another alphacoronavirus, *Human coronavirus NL63* (HCoV-NL63), was isolated from a seven-month-old child in the Netherlands suffering from bronchiolitis and conjunctivitis (Pyrc *et al.*, 2004[@bb19]). In 2005, Woo and coworkers discovered the novel betacoronavirus *Human coronavirus HKU1* in patients with respiratory-tract infections (Woo *et al.*, 2005[@bb24]). Recently, *Middle East respiratory syndrome coronavirus* (MERS-CoV) has been found in patients with severe acute respiratory-tract infections in the Middle East (Woo *et al.*, 2014[@bb25]). As is the case for all coronaviral infections, there are no efficacious therapies currently available against coronaviral diseases, making the development of anti­coronaviral compounds a priority. The virion envelope surrounding the nucleocapsid contains the following structural proteins: S (spike), M (matrix), E (envelope) and N (nucleocapsid). Some of them have a third glycoprotein, HE (haemagglutinin-esterase), which is present in most alphacoronaviruses. The primary function of the HCoV N protein is to recognize a stretch of RNA that serves as a packaging signal and leads to the formation of the ribonucleoprotein (RNP) complex during assembly (Chang *et al.*, 2014[@bb2]). The RNP may be important in keeping the RNA in an ordered conformation suitable for replication and transcription of the viral genome (Lai, 2003[@bb10]; Nelson *et al.*, 2000[@bb17]; Huang *et al.*, 2004[@bb8]; Navas-Martín & Weiss, 2004[@bb16]). In addition, the N protein has been identified as an important diagnostic marker and the most 'immunodominant' antigen in infected hosts (Chan *et al.*, 2005[@bb1]; Woo *et al.*, 2004[@bb26]; Liang *et al.*, 2013[@bb11]).

The N protein of MERS-CoV, with a molecular weight of 45.6 kDa and a pI of 10.05, is highly basic and hydrophilic (Woo *et al.*, 2014[@bb25]). Previous studies revealed that the N-terminal domain of CoV (NP-NTD) contains mostly positively charged residues, which are responsible for RNA binding, while the C-terminal domain (NP-CTD) mainly acts as an oligomerization module to form a capsid (Huang *et al.*, 2009[@bb7]; Saikatendu *et al.*, 2007[@bb20]; Lo *et al.*, 2013[@bb13]; Chen *et al.*, 2013[@bb5]). The central disordered region of the N protein has also been shown to contain an RNA-binding region (Chang *et al.*, 2009[@bb3]). We have shown that compounds that bind to the NP-NTD and interfere with NP--RNA interactions provide valuable leads for the development of anti-coronaviral therapeutics (Lin *et al.*, 2014[@bb12]). The crystal structures of several NP-NTDs, including those from SARS-CoV, *Infectious bronchitis virus* (IBV), *Human coronavirus OC43* (HCoV-OC43) and *Mouse hepatitis virus* (MHV), have been described (Chen *et al.*, 2013[@bb5]; Ma *et al.*, 2010[@bb14]; Saikatendu *et al.*, 2007[@bb20]; Jayaram *et al.*, 2006[@bb9]; Yu *et al.*, 2006[@bb27]; Fan *et al.*, 2005[@bb6]). In order to clarify the mechanism by which the N protein of MERS-CoV bind to nucleic acids, we have undertaken the determination of the crystal structure of the N-terminal domain of MERS-CoV spanning residues 39--165, which shares 58% identity to NP-NTD of SARS-CoV. The results presented in this paper mainly concern the crystallization and preliminary X-ray structural analysis of MERS-CoV NP-NTD.

2.. Materials and methods   {#sec2}
===========================

2.1.. Macromolecule production   {#sec2.1}
--------------------------------

The templates for the MERS-CoV N protein were purchased from AllBio Science Incorporated, Taichung, Taiwan. Truncated forms of recombinant MERS-CoV NP-NTD were generated by polymerase chain reaction (PCR) of a pGENT plasmid encoding the N-protein gene using different primers. The PCR products were digested with NdeI and XhoI, and the DNA fragments were cloned into pET-28a (Novagen) using T4 ligase (NEB). Expression of the protein was initiated by adding IPTG to a final concentration of 1 m*M* followed by incubation at 10°C for 24 h. After harvesting the bacteria by centrifugation (8000 rev min^−1^, 12 min, 4°C), the bacterial pellets were resuspended in lysis buffer (50 m*M* Tris--HCl, 150 m*M* NaCl, 15 m*M* imidazole, 1 m*M* PMSF pH 7.5) and lysed by sonication on ice using 3 s pulses with 6 s pauses for a total of 10 min. Soluble proteins were obtained from the supernatant after centrifugation (13 000 rev min^−1^, 40 min, 4°C). NP-NTD carrying an N-terminal His~6~ tag fused to a SSGLVPRGSHM linker sequence was purified using an Ni--NTA column (Novagen) and eluted with a buffered imidazole gradient of 15--250 m*M*. Fractions containing pure protein were collected at ∼150 m*M* imidazole and were dialyzed against 50 m*M* Tris-buffered solution at pH 7.5 containing 150 m*M* NaCl for 3 h at 4°C (Fig. 1[▸](#fig1){ref-type="fig"}). The purified NP-NTD was further concentrated using Amicon Ultra centrifugal filter units and centrifuged at 3500*g* for 10 min at 4°C several times until the concentration of NP-NTD reached 10 mg ml^−1^ as determined by the Bradford method (BioShop Canada Inc.). Macromolecule-production information is summarized in Table 1[▸](#table1){ref-type="table"}.

2.2.. Crystallization   {#sec2.2}
-----------------------

Initial crystallization conditions were identified by using the sitting-drop vapour-diffusion method with crystal screening kits from Molecular Dimensions as described previously (Till *et al.*, 2013[@bb22]; Chen *et al.*, 2014[@bb4]). Each of the solutions (2 µl) from the crystal screening kits was mixed with 2 µl purified protein solution (10 mg ml^−1^) and allowed to equilibrate against 300 µl solution in the well at room temperature (∼25°C). The conditions were refined and crystals were grown from a well solution using the sitting-drop vapour-diffusion method by equilibrating a mixture of 2 µl protein solution (10 mg ml^−1^) and 2 µl reservoir solution against 300 µl reservoir solution consisting of 2 m*M* NaBr, 75 m*M* ammonium sulfate, 29% PEG 3350 (Sigma). Crystals appeared within two weeks and the largest crystal in the needle clusters grew to dimensions of approximately 300 × 20 × 10 µm (Fig. 2[▸](#fig2){ref-type="fig"}). Crystallization information is summarized in Table 2[▸](#table2){ref-type="table"}.

2.3.. Data collection and processing   {#sec2.3}
--------------------------------------

X-ray data were collected using synchrotron radiation with a crystal-to-detector distance of 350 mm. The oscillation width and exposure time for each frame were 1° and 20 s, respectively. Crystallographic data integration and reduction were performed with the *HKL*-2000 program package (Otwinowski & Minor, 1997[@bb18]). The crystallographic data-collection statistics for NP-NTD are listed in Table 3[▸](#table3){ref-type="table"}.

3.. Results and discussion   {#sec3}
============================

The MERS-CoV NP-NTD crystal chosen for this study diffracted to 2.63 Å resolution (Fig. 3[▸](#fig3){ref-type="fig"}) and belonged to space group *P*2~1~, with unit-cell parameters *a* = 35.60, *b* = 109.64, *c* = 91.99 Å, β = 101.22°. The Matthews coefficient of 2.63 Å^3^ Da^−1^ calculated using *MATTHEWS_COEF* from *CCP*4 (Winn *et al.*, 2011[@bb28]; Matthews, 1968[@bb15]) suggested that there were four molecules in an asymmetric unit with a solvent content of 59.2%. A homology search for the MERS-CoV NP-NTD structure was performed using the *BLAST* server (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>). The model-selection criterion was based on the *E*-value and the estimated precision value. The sequence-alignment search indicated that MERS-CoV NP-NTD shares high identity with other NP-NTDs from coronaviruses (Supplementary Fig. S1). For example, the MERS-CoV NP-NTD (residues 39--165) has 58% sequence identity to SARS-CoV NP-NTD. The NTD from SARS-CoV (PDB entry [2ofz](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=2ofz); Saikatendu *et al.*, 2007[@bb20]) was chosen as the initial model as its *E*-value was 1 × 10^−23^, and a total of 116 residues were modelled. The first molecular-replacement trial was performed using the *PERON* automated interface at the Protein Tectonics Platform (PTP), RIKEN SPring-8 Center, Japan (Sugahara *et al.*, 2008[@bb21]). The core of the model consisted of a tightly packed β-sheet surrounded by large loops. The molecular-replacement method was then applied to the model using *MOLREP* (Vagin & Teplyakov, 2010[@bb23]) using reflections in the resolution range 8.5--3.0 Å. Single and unambiguous solutions for four NP-NTD molecules in one asymmetric unit were obtained in the rotation and translation functions, yielding a final correlation coefficient of 0.81 and an *R* factor of 0.32. Structural refinement of MERS-CoV NP-NTD is currently in progress.
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![SDS--PAGE analysis of MERS-CoV NP-NTD stained with Coomassie Brilliant Blue. Lane *M*, protein molecular-mass marker (labelled in kDa); lane 1, concentrated MERS-CoV NP-NTD after dialysis; lane 2, purified MERS-CoV NP-NTD.](f-71-00977-fig1){#fig1}

![Crystals of MERS-CoV NP-NTD obtained by the sitting-drop vapour-diffusion method. The largest crystals in the needle clusters are approximately 300 × 20 × 10 µm in size.](f-71-00977-fig2){#fig2}

![Typical X-ray diffraction pattern of MERS-CoV NP-NTD.](f-71-00977-fig3){#fig3}

###### Macromolecule-production information

  -------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source organism                                          *Middle East respiratory syndrome coronavirus*
  DNA source                                               The templates for the MERS-CoV N protein were provided by AllBio Science Incorporation, Taichung, Taiwan. The primers for the MERS-CoV N protein were provided by Genomics BioSci Tech Ltd, New Taipei City, Taiwan.
  Forward primer                                           CTTATCG[CATATG]{.ul}AACACCGTGAGCTGGTATACCGGC
  Reverse primer                                           CTTACGG[CTCGAG]{.ul}GGTGCCTTCAATATGAAAGTTTTTCG
  Cloning vector                                           pET-28a (Novagen)
  Expression vector                                        pET-28a (Novagen)
  Expression host                                          *Escherichia coli* BL21 (DE3) pLysS
  Complete amino-acid sequence of the construct produced   HHHHHHSSGLVPRGSHMNTVSWYTGLTQHGKVPLTFPPGQGVPLNANSTPAQNAGYWRRQDRKINTGNGIKQLAPRWYFYYTGTGPEAALPFRAVKDGIVWVHEDGATDAPSTFGTRNPNNDSAIVTQFAPGTKLPKNFHIEGT
  -------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### Crystallization

  ---------------------------------------- ------------------------------------------------------------------------
  Method                                   Vapour diffusion
  Plate type                               24-well sitting-drop plate (Hampton Research)
  Temperature (K)                          293
  Protein concentration (mgml^1^)          10
  Buffer composition of protein solution   50m*M* TrisHCl pH 7.5, 75m*M* NaCl
  Composition of reservoir solution        2m*M* NaBr, 75m*M* ammonium sulfate, 29% PEG 3350
  Volume and ratio of drop                 1:1; 2l reservoir solution was mixed with 2l purified protein solution
  Volume of reservoir (l)                  300
  ---------------------------------------- ------------------------------------------------------------------------

###### Data collection and processing

Values in parentheses are for the outer shell.

  ------------------------------------------- ------------------------------------------------------------------------------------------
  Diffraction source                          BL13B1 beamline, National Synchrotron Radiation Research Center (NSRRC), Hsinchu, Taiwan
  Wavelength ()                               1.000
  Temperature (K)                             77
  Detector                                    ADSC Q315r
  Crystal-to-detector distance (mm)           350
  Rotation range per image ()                 1
  Total rotation range ()                     360
  Exposure time per image (s)                 20
  Space group                                 *P*2~1~
  *a*, *b*, *c* ()                            35.60, 109.64, 91.99
  , , ()                                      90, 101.22, 90
  Mosaicity ()                                1.053
  Resolution range ()                         302.63 (2.732.63)
  Total No. of reflections                    138439
  No. of unique reflections                   13974
  Completeness (%)                            94.5 (91.4)
  Multiplicity                                7.1 (5.9)
  *I*/(*I*)                                   18.89 (3.03)
  *R* ~r.i.m.~                                0.01 (0.08)
  Overall *B* factor from Wilson plot (^2^)   43.1
  ------------------------------------------- ------------------------------------------------------------------------------------------
